Somatic compensation of inherited bone marrow failure.
Clonal hematopoiesis
Inherited bone marrow failure syndromes
Somatic compensation
Journal
Seminars in hematology
ISSN: 1532-8686
Titre abrégé: Semin Hematol
Pays: United States
ID NLM: 0404514
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
23
05
2022
revised:
11
07
2022
accepted:
28
07
2022
entrez:
17
9
2022
pubmed:
18
9
2022
medline:
21
9
2022
Statut:
ppublish
Résumé
Inherited bone marrow failure syndromes (IBMFS) are a heterogeneous group of genetic disorders characterized by insufficient blood cell production and increased risk of transformation to myeloid malignancies. While genetically diverse, IBMFS are collectively defined by a cell-intrinsic hematopoietic stem cell (HSC) fitness defect that impairs HSC self-renewal and hematopoietic differentiation. In IBMFS, HSCs frequently acquire mutations that improve cell fitness, a phenomenon known as somatic compensation. Somatic compensation can occur via distinct genetic processes such as loss of the germline mutation or somatic alterations in pathways affected by the disease-causing gene. While the clinical implications of somatic compensation in IBMFS remain to be fully discovered, understanding these mutational processes can help understand disease pathophysiology and may inform future diagnostic and therapeutic approaches. In this review, we highlight current understanding about somatic compensation in IBMFS.
Identifiants
pubmed: 36115694
pii: S0037-1963(22)00040-3
doi: 10.1053/j.seminhematol.2022.07.002
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
167-173Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.